Canada - English - Health Canada

teva canada limited - remifentanil (remifentanil hydrochloride) - powder for solution - 1mg - remifentanil (remifentanil hydrochloride) 1mg - opiate agonists

Canada - English - Health Canada

teva canada limited - remifentanil (remifentanil hydrochloride) - powder for solution - 2mg - remifentanil (remifentanil hydrochloride) 2mg - opiate agonists

Malta - English - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - remifentanil - concentrate for solution for infusion or injection - remifentanil 1 mg - anesthetics

Kenya - English - Pharmacy and Poisons Board

beta healthcare international limited plot no. lr 209/6554, mogadishu road, industrial - remifentanil hydrochloride - powder for injection - 1mg - general anesthetics: opioidanesthetics

Kenya - English - Pharmacy and Poisons Board

beta healthcare international limited plot no. lr 209/6554, mogadishu road, industrial - remifentanil hydrochloride - powder for injection - 2mg - general anesthetics: opioidanesthetics

Kenya - English - Pharmacy and Poisons Board

beta healthcare international limited plot no. lr 209/6554, mogadishu road, industrial - remifentanil hydrochloride - powder for injection - 5mg - general anesthetics: opioidanesthetics

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - voriconazole, quantity: 200 mg - solution, powder for - excipient ingredients: hydroxypropylbetadex; hydrochloric acid; sodium chloride - voriconazole is indicated for treatment of the following fungal infections:,- invasive aspergillosis.,- serious candida infections (including c. krusei), including oesophageal and systemic candida infections (hepatosplenic candidiasis, disseminated candidiasis, candidaemia).,- serious fungal infections caused by scedosporium spp. and fusarium spp.,- other serious fungal infections, in patients intolerant of, or refractory to, other therapy.,- prophylaxis in patients who are at high risk of developing invasive fungal infections. the indication is based on studies including patients undergoing haematopoietic stem cell transplantation.

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - voriconazole, quantity: 200 mg - injection, powder for - excipient ingredients: arginine; sodium hydroxide; dilute hydrochloric acid; hydroxypropylbetadex - voriconazole is indicated for treatment of the following fungal infections:,- invasive aspergillosis.,- serious candida infections (including c. krusei), including systemic candida infections (hepatosplenic candidiasis, disseminated candidiasis, candidaemia).,- serious fungal infections caused by scedosporium spp. and fusarium spp.,- other serious fungal infections, in patients intolerant of, or refractory to, other therapy.,prophylaxis in patients who are at high risk of developing invasive fungal infections. the indication is based on studies including patients undergoing haematopoietic stem cell transplantation.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - parecoxib sodium, quantity: 42.36 mg (equivalent: parecoxib, qty 40 mg) - injection, powder for - excipient ingredients: sodium hydroxide; phosphoric acid; dibasic sodium phosphate - for a single peri-operative dose for the management of post-operative pain.

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

fresenius kabi sa-nv - remifentanil hydrochloride 1,1 mg - eq. remifentanil 1 mg - powder for concentrate for solution for injection/infusion - 1 mg - remifentanil hydrochloride 1.1 mg - remifentanil